Owner Raptor Pharmaceutical Inc.

Inventors Kennard, Malcolm L.; Beliveau, Richard; Gabathuler, Reinhardt; Yang, Joseph; Demeule, Michel

Agent Wrays

Pub. Number AU-B-2002322720

PCT Number PCT/US02/23923

PCT Pub. Number WO2003/009815

Priority 60/308,002 25.07.01 US

Filing date 25 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 13 November 2008

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/79 (2006.01) Peptides having more than 20 amino acids

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine